# Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

> **NCT03902665** · PHASE2 · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 19 (actual)

## Conditions studied

- Acute Myeloid Leukemia, Adult

## Interventions

- **DRUG:** Up-front allogeneic hematopoietic stem cell transplantation (HSCT)

## Key facts

- **NCT ID:** NCT03902665
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-15
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902665, "Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03902665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*